Plans IND Submission for Same Cells to Treat COVID-19 Induced Acute Respiratory Distress Syndrome AN CARLOS, Calif., May 05, 2020 (GLOBE NEWSWIRE) — BioCardia®, Inc. [Nasdaq: BCDA], a leader in the development of comprehensive solutions for cardiovascular regenerative therapies, today announced data from a recent animal study performed by the Company that […]
Other News
Semler Reports First Quarter 2020 Financial Results
2020 Q1 HIGHLIGHTS compared to the corresponding period of 2019: – Revenues were $9,430,000, which is an increase of 39% – Pre-tax net income of $3,450,000, an increase of $1,596,000, or 86%, compared to $1,854,000 – Net income grew to $0.41 per basic share and $0.33 per diluted share, compared […]
FineHeart Completes First Successful Chronic In-Vivo Study of its ICOMS Device Intended for the Treatment of Severe Heart Failure
First destination therapy that restores natural heart pumping capacity; potential game changer for more than 200,000 untreated severe heart failure patients per year BORDEAUX, France–(BUSINESS WIRE)–FineHeart, a French medical device company, today announced the success of a seven-day preclinical study to evaluate its Implantable Cardiac Output Management System (ICOMS), the […]
LifeSignals Receives CE Mark Approval for LifeSignals ECG Remote Monitoring Patch Platform (LX1250E)
Continuous patient monitoring with remote data access in ambulatory, hospital and home settings enables faster clinical decision making FREMONT, California, May 5, 2020 /PRNewswire/ — LifeSignals, today announced the awarding of the CE (Conformité Européene) Mark for their LifeSignals ECG Remote Monitoring Patch – a disposable wireless remote monitoring system, intended for […]
Acesion Pharma Strengthens Clinical Team With Key Appointments
Appoints experienced Chief Medical Officer and Director Clinical Operations COPENHAGEN, Denmark, May 5, 2020 /PRNewswire/ — Acesion Pharma, a Danish pharmaceutical company developing novel treatments for atrial fibrillation (AF), the most common cardiac arrhythmia, today announced that it has recruited Anders Gaarsdal Holst as its Chief Medical Officer (CMO) to succeed Nils Edvardsson, who […]
FDA Grants Emergency Use Authorization to VitalConnect for Cardiac Monitoring in COVID-19 Patients
VitalPatch® wearable biosensor can monitor for heart-related side effects of Hydroxychloroquine and other COVID-19 treatments SAN JOSE, Calif., May 5, 2020 /PRNewswire/ — VitalConnect®, Inc., a leader in wearable biosensor technology, announced it was granted Emergency Use Authorization (EUA) status by the U.S. Food and Drug Administration (FDA) as part of the response to the […]
ZOLL THEROX RECEIVES CE MARK APPROVAL FOR SUPERSATURATED OXYGEN THERAPY
May 4, 2020 — CHELMSFORD, MASS. — ZOLL® Medical Corporation, an Asahi Kasei Group Company that manufactures medical devices and related software solutions, announced today it has received CE Mark approval to market and distribute its SuperSaturated Oxygen (SSO2) Therapy System in Europe. SSO2 Therapy provides interventional cardiologists with the first and only clinically proven […]
BioMarin Extends Gene Therapy Leadership with DiNAQOR in a Preclinical Collaboration and License Agreement to Develop Gene Therapies for Rare Genetic Cardiomyopathies
SAN RAFAEL, Calif., May 3, 2020 /PRNewswire/ — BioMarin Pharmaceutical Inc. (Nasdaq: BMRN) today announced that the company has entered into a preclinical collaboration and license agreement with DiNAQOR AG (DiNAQOR), a gene therapy platform company, to develop novel gene therapies to treat rare genetic cardiomyopathies. DiNAQOR will receive an undisclosed upfront payment […]
Venus Medtech and Opus Medical Therapies, LLC Announce Partnership for Transcatheter Mitral Valve Replacement (TMVR) and Transcatheter Tricuspid Valve Replacement (TTVR) in Greater China Market
HANGZHOU, China and ATLANTA, May 2, 2020 /PRNewswire/ — Venus Medtech (Hangzhou) Inc. (“Venus Medtech” or the “Company”, together with its subsidiaries, the “Group”, stock code: 2500), the leading Chinese transcatheter heart valve company and Opus Medical Therapies, LLC, a medical device company focused on developing transcatheter mitral and tricuspid valve replacement products for patients undergoing […]
Centerline Biomedical Completes First Human Patient in the United States with IOPS™ (Intra-Operative Positioning System)
Fast-growing startup company continues to execute key milestones and begins first in-market use of novel endovascular navigation technology CLEVELAND, May 4, 2020 /PRNewswire/ — Surgical navigation startup Centerline Biomedical, Inc. (Centerline), a Cleveland Clinic spin-off company, has announced the successful completion of the first in a series clinical cases in the United States as […]
Recent
FLEX Vascular Announces 12-Month Real-World Outcomes Demonstrating Strong Safety, Durability, and Reduced Reinterventions with FLEX™ Vessel Prep System
NorthStar Mapping System Now Commercially Available in the United States
HOPPR Expands Medical Imaging AI Portfolio with Chest Radiography Narrative Model
Popular
- No commented posts yet